CliffBio
small molecule

AZELASTINE HYDROCHLORIDE

AZELASTINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameAZELASTINE HYDROCHLORIDE
Active ingredientAZELASTINE HYDROCHLORIDE
Strength0.05%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalAugust 2009
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.